ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

HEMO Hemogenyx Pharmaceuticals Plc

1.31
0.02 (1.55%)
28 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.02 1.55% 1.31 1.282 1.338 1.326 1.272 1.29 5,347,757 16:35:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -6.69M -0.0050 -2.60 17.44M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.29p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.25p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,341,815,988 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £17.44 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -2.60.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 2501 to 2517 of 13450 messages
Chat Pages: Latest  106  105  104  103  102  101  100  99  98  97  96  95  Older
DateSubjectAuthorDiscuss
23/4/2020
12:09
What's the low today then ?

2p offer maybe, so many day traders piled in yesterday and a lot of them obviously selling to use their money on something hot elsewhere

dave4545
23/4/2020
11:12
You're right the abbot...

You should not ignore davevt - he is master of trading. we all should learn from the Great dave and Shukan

both are genius in their own area.. one ramping and one deramping.

Okay enough for today.

I will just leave it here with one suggestion again - PLEASE PLEASE READ ALL RNS OF HEMO FOR LAST 2 YEAR... PLEASE READ.

Happy to forward email ( or just see here history of Marie ) to personal mail from Dr. how he ramped.

idontflykathyy
23/4/2020
11:11
I'm the only one that's made money, called everything right 😂
davevt
23/4/2020
11:08
true davevt,

For some reason i always buy at top/peak level and sell at lower level.

Not everyone as smart as you ;)

Now mumma is calling you for tea - my 4 feet 5 inch baldie ;)

idontflykathyy
23/4/2020
11:07
It's very easy not to lose Kathy, watch a share long enough, find the bottom.

I always said only buy at sub 1.8.....even with the recent pandemic, it only dropped a little lower.

That's how you don't lose money.

Unlike yourself who listened to badger the ramper and lost everything 😂

davevt
23/4/2020
11:01
yes abott - one more thing.

davevt is the only trader/investor i ever know who never lost a single trade/investing.

Amazing... but he will never tell you or reveal his trades. you know just demo account lol

idontflykathyy
23/4/2020
10:56
the abbot,

Sorry that was a sarcasm. Sorry for that.

Hemo never reached at 7p. Peak was 4.9P.

Below is my price as i said in my earlier messages... and sold just a day before.

I am happy to foward email from Dr. Sandler which could be eye opener for you!

10/01/2020 14/01/2020 B527638772 Hemogenyx Pharmaceuticals Plc Ordinary Shares 1p
183634 @ 1.89 1.89 183,634 -3,499.98
10/01/2020 14/01/2020 B527637632 Hemogenyx Pharmaceuticals Plc Ordinary Shares 1p
517622 @ 1.92 1.92 517,622 -9,999.98

idontflykathyy
23/4/2020
10:14
Yes the abbot - bought at 7p and sold at 1p.

So imagine my situation ;)

I'm frustated with how this company works so i am just spreading the news. Thanks to my deramping someone astleast managed to sell yesterday.

idontflykathyy
23/4/2020
10:08
Shukan,

Thanks to me there are couple of members here sold at 2.4 level. And they replied me personally to Thank you.

I've burned long here and now I should educated others about this company.

Simple.

Unlike you in twitter under Shukan, just ramping like Dr. Sandler

idontflykathyy
23/4/2020
10:05
Kathy....you said you were not going to post again...yet here you are trying to slag off the share now you have sold out..

Just go away and do your usual line of coke now you have some money

johntopdog
23/4/2020
09:59
In fact, one should read all RNS for last 2 years..

Eye opener..

idontflykathyy
23/4/2020
09:56
Now the frustation starts for LTH.

Cmon guys - atleast read the RNS again.

Please read RNS again.. nothing there. just "could" and "may"

Open your eyes.

idontflykathyy
23/4/2020
09:31
Re Post 1652

I suspect there may be many applications for the unique solution subject of the pilot study, if successful.

Perhaps we should forecast, (guess), a few.

tullynessle
23/4/2020
09:26
IMO, the paragraph at Extract below offers great potential for Hemogenyx, if the pilot study is successful, noting that no other proposed solution from other Pharma has sought to disclose such work.

Daily we are advised that there are three requirements for bringing "Lockdown" to an end, notwithstanding that social distancing, in some form, is likely to remain for an extended period.

1. Access to a vaccine
2. Access and acceptance of contact-tracing
3. Availability of Drugs to mitigate the symptoms of COV-19.

Apparently, all are some way off, with 2 & 3 potentially closer than 1.

Is it possible that the (unique?) research being undertaken by Hemogenyx and as described at Extract, be used as another component of the "release from Lockdown" decision, with those "at LOW risk of severe illness caused by the virus" being released earlier than those at HIGH risk of severe illness?



Extract:

"Concurrently, Hemogenyx has initiated a pilot study to understand why some individuals who are infected with SARS-CoV-2 are asymptomatic, some exhibit mild symptoms and some become very sick. Such understanding could prove essential for both the development of new treatments for COVID-19 and managing the current risk of infection. Should the study prove to be successful, Hemogenyx will aim to develop and commercialize a test that could identify people with potentially high/low risk of severe illness caused by the virus."





Hemogenyx Pharmaceuticals PLC COVID-19 Project Initiated / RNS April 22


Hemogenyx to use its advanced humanized mice to develop potential treatments for COVID-19

RNS continues.....

tullynessle
23/4/2020
09:05
Oh and look, I'm right again, she's down again, thought you said it was gonna rise John?

Are you ever gonna get anything right, ever? 😂

davevt
23/4/2020
09:00
No John 😂



11.19 i posted, not even 2 minutes after...

davevt
22/4/2020
23:27
John,

Is it true you hold 80% of hemo share ?

idontflykathyy
Chat Pages: Latest  106  105  104  103  102  101  100  99  98  97  96  95  Older

Your Recent History

Delayed Upgrade Clock